BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15734867)

  • 21. Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition.
    Stimson RH; Andrew R; McAvoy NC; Tripathi D; Hayes PC; Walker BR
    Diabetes; 2011 Mar; 60(3):720-5. PubMed ID: 21266326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
    Rask E; Walker BR; Söderberg S; Livingstone DE; Eliasson M; Johnson O; Andrew R; Olsson T
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3330-6. PubMed ID: 12107245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 11beta-Hydroxysteroid dehydrogenase type 1-driven cortisone reactivation regulates plasminogen activator inhibitor type 1 in adipose tissue of obese women.
    Ayachi SE; Paulmyer-Lacroix O; Verdier M; Alessi MC; Dutour A; Grino M
    J Thromb Haemost; 2006 Mar; 4(3):621-7. PubMed ID: 16460444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol.
    Andrew R; Smith K; Jones GC; Walker BR
    J Clin Endocrinol Metab; 2002 Jan; 87(1):277-85. PubMed ID: 11788660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 11Beta-hydroxysteroid dehydrogenase type 1 in human disease: a novel therapeutic target.
    Tomlinson JW
    Minerva Endocrinol; 2005 Mar; 30(1):37-46. PubMed ID: 15877012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary macronutrient content alters cortisol metabolism independently of body weight changes in obese men.
    Stimson RH; Johnstone AM; Homer NZ; Wake DJ; Morton NM; Andrew R; Lobley GE; Walker BR
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4480-4. PubMed ID: 17785367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An in vivo microdialysis coupled with liquid chromatography/tandem mass spectrometry study of cortisol metabolism in monkey adipose tissue.
    Sun L; Stenken JA; Brunner JE; Michel KB; Adelsberger JK; Yang AY; Zhao JJ; Musson DG
    Anal Biochem; 2008 Oct; 381(2):214-23. PubMed ID: 18638442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity.
    Tomlinson JW; Finney J; Gay C; Hughes BA; Hughes SV; Stewart PM
    Diabetes; 2008 Oct; 57(10):2652-60. PubMed ID: 18633104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes.
    Abdallah BM; Beck-Nielsen H; Gaster M
    Eur J Clin Invest; 2005 Oct; 35(10):627-34. PubMed ID: 16178882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
    Wiegand S; Richardt A; Remer T; Wudy SA; Tomlinson JW; Hughes B; Grüters A; Stewart PM; Strasburger CJ; Quinkler M
    Eur J Endocrinol; 2007 Sep; 157(3):319-24. PubMed ID: 17766714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
    Nuotio-Antar AM; Hachey DL; Hasty AH
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1517-28. PubMed ID: 17878220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.
    Tomlinson JW; Moore JS; Clark PM; Holder G; Shakespeare L; Stewart PM
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2711-6. PubMed ID: 15181046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated measurements of 11β-HSD-1 activity in subcutaneous adipose tissue from lean, abdominally obese, and type 2 diabetes subjects--no change following a mixed meal.
    Sjöstrand M; Jansson PA; Palming J; de Schoolmeester J; Gill D; Rees A; Sjögren L; Persson T; Eriksson JW
    Horm Metab Res; 2010 Oct; 42(11):798-802. PubMed ID: 20514603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle.
    Stewart PM; Toogood AA; Tomlinson JW
    Horm Res; 2001; 56 Suppl 1():1-6. PubMed ID: 11786677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
    Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M
    J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
    Paulsen SK; Pedersen SB; Fisker S; Richelsen B
    Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
    Tomlinson JW; Sinha B; Bujalska I; Hewison M; Stewart PM
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5630-5. PubMed ID: 12466364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo evaluation of 11beta-hydroxysteroid dehydrogenase activity in the rabbit eye.
    Anderson S; Carreiro S; Quenzer T; Gale D; Xiang C; Gukasyan H; Lafontaine J; Cheng H; Krauss A; Prasanna G
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):215-22. PubMed ID: 19456256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation.
    Walker BR; Connacher AA; Lindsay RM; Webb DJ; Edwards CR
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3155-9. PubMed ID: 7593419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.